Agenus, Inc. (AGEN)

8.24 0.00 (0.00%) USD  |  NASDAQ  |  Sep 04, 16:00
8.25 +0.01 (+0.12%) After-Hours: 20:00
More

Agenus SG&A Expense (TTM) : 38.48M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 38.48M
March 31, 2026 45.53M
December 31, 2025 54.39M
September 30, 2025 63.03M
June 30, 2025 69.44M
March 31, 2025 70.74M
December 31, 2024 71.88M
September 30, 2024 72.12M
June 30, 2024 73.76M
March 31, 2024 77.36M
December 31, 2023 78.74M
September 30, 2023 82.60M
June 30, 2023 81.79M
March 31, 2023 80.29M
December 31, 2022 81.01M
September 30, 2022 77.94M
June 30, 2022 81.22M
March 31, 2022 78.96M
December 31, 2021 76.36M
September 30, 2021 74.42M
June 30, 2021 67.41M
March 31, 2021 64.96M
December 31, 2020 59.22M
September 30, 2020 51.51M
June 30, 2020 48.64M
Date Value
March 31, 2020 45.85M
December 31, 2019 46.04M
September 30, 2019 43.45M
June 30, 2019 41.14M
March 31, 2019 39.22M
December 31, 2018 37.34M
September 30, 2018 37.40M
June 30, 2018 36.25M
March 31, 2018 34.90M
December 31, 2017 33.74M
September 30, 2017 32.63M
June 30, 2017 32.68M
March 31, 2017 31.66M
December 31, 2016 33.13M
September 30, 2016 32.92M
June 30, 2016 31.22M
March 31, 2016 32.12M
December 31, 2015 28.37M
September 30, 2015 25.28M
June 30, 2015 23.80M
March 31, 2015 21.63M
December 31, 2014 21.30M
September 30, 2014 19.30M
June 30, 2014 17.96M
March 31, 2014 16.76M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Novavax, Inc. 121.22M
Amgen, Inc. 7.019B
Anika Therapeutics, Inc. 52.67M
BioCryst Pharmaceuticals, Inc. 328.11M
Imunon, Inc. 6.645M